Some animals are more equal than others [BE/BA News]

posted by Lucas – Brazil, 2014-10-14 19:02 (3855 d 04:08 ago) – Posting: # 13706
Views: 14,041

Hi everybody!

❝ Maybe. The origin of these limits lies in the dark ages.

Reference-scaling for HVDPs is dependent on the CVWR estimated in particular studies. That’s completely different from the “one size fits all” 80/125-concept. Sooner or later we will have generics of HVDPs on the market which were approved according to different rules.


I would love to see studies showing that the 80-125% and also Reference-scaling are actually good. I'm not an expert in physiology, and maybe that's the problem, but I think that this is a very strong statement when you say that some drugs does not show difference in efficacy/safety when the 80-125% criteria is applied. Even worst may be for HVDPs. It is scientifically proved that higher the CV wider is the therapeutic index? Do all drugs, regardless of class or indication, have similar PBPK/PD relation?

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,667 registered users;
37 visitors (0 registered, 37 guests [including 7 identified bots]).
Forum time: 23:11 CEST (Europe/Vienna)

Patients may recover in spite of drugs or because of them.    John Gaddum

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5